136 related articles for article (PubMed ID: 21866115)
1. The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.
Carvalho A; Cunha C; Almeida AJ; Osório NS; Saraiva M; Teixeira-Coelho M; Pedreiro S; Torrado E; Domingues N; Gomes-Alves AG; Marques A; Lacerda JF; da Silva MG; Gomes M; Pinto AC; Torres F; Rendeiro P; Tavares P; Di Ianni M; Medeiros R; Heutink P; Bracci PM; Conde L; Ludovico P; Pedrosa J; Maciel P; Pitzurra L; Aversa F; Marques H; Paiva A; Skibola CF; Romani L; Castro AG; Rodrigues F
Genes Immun; 2012 Feb; 13(2):197-201. PubMed ID: 21866115
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
3. Association of TLR9-1237T>C; rs5743836 polymorphism with increased risk of Hodgkin's lymphoma: A case-control study.
Al-Khatib S; Shabaneh A; Abdo N; Al-Eitan L; Al-Mistarehi AH; Khader Y
PLoS One; 2022; 17(7):e0272312. PubMed ID: 35905120
[TBL] [Abstract][Full Text] [Related]
4. Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.
Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
J Thromb Thrombolysis; 2017 Jul; 44(1):130-138. PubMed ID: 28321710
[TBL] [Abstract][Full Text] [Related]
5. The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation.
Carvalho A; Osório NS; Saraiva M; Cunha C; Almeida AJ; Teixeira-Coelho M; Ludovico P; Pedrosa J; Pitzurra L; Aversa F; Romani L; Castro AG; Rodrigues F
PLoS One; 2011; 6(11):e28256. PubMed ID: 22132241
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes.
Lange NE; Zhou X; Lasky-Su J; Himes BE; Lazarus R; Soto-Quirós M; Avila L; Celedón JC; Hawrylowicz CM; Raby BA; Litonjua AA
BMC Med Genet; 2011 Feb; 12():26. PubMed ID: 21324137
[TBL] [Abstract][Full Text] [Related]
7. Analysis of toll-like receptors-9 (TLR9) gene polymorphism (rs5743836) in Pakistani patients with HCV.
Aslam N; Batool F; Iqbal MS; Ashfaq UA; Ayaz S; Khaliq S; Jahan S; Ghani MU; Usman M
Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2709-2714. PubMed ID: 30587483
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
[TBL] [Abstract][Full Text] [Related]
9. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
11. TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism.
Noack J; Jordi M; Zauner L; Alessi D; Burch A; Tinguely M; Hersberger M; Bernasconi M; Nadal D
Cell Death Dis; 2012 Jun; 3(6):e323. PubMed ID: 22717578
[TBL] [Abstract][Full Text] [Related]
12. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
Cao C; Liu S; Lou SF; Liu T
Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection.
Fischer J; Weber ANR; Böhm S; Dickhöfer S; El Maadidi S; Deichsel D; Knop V; Klinker H; Möller B; Rasenack J; Wang L; Sharma M; Hinrichsen H; Spengler U; Buggisch P; Sarrazin C; Pawlita M; Waterboer T; Wiese M; Probst-Müller E; Malinverni R; Bochud PY; Gardiner C; O'Farrelly C; Berg T
Gut; 2017 Oct; 66(10):1829-1837. PubMed ID: 27196570
[TBL] [Abstract][Full Text] [Related]
14. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
[TBL] [Abstract][Full Text] [Related]
16. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
17. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
[TBL] [Abstract][Full Text] [Related]
18. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
19. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
Purdue MP; Hartge P; Davis S; Cerhan JR; Colt JS; Cozen W; Severson RK; Li Y; Chanock SJ; Rothman N; Wang SS
Cancer Causes Control; 2007 Nov; 18(9):989-99. PubMed ID: 17653830
[TBL] [Abstract][Full Text] [Related]
20. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
